Ryan Wonhyoung Jung has been leading the executive management and commercial affairs of Excolo since its establishment in 2018. As a registered Certified Public Accountant, he has extensive experience in consulting, financial advisory, auditing, and accounting for both global and local companies. Prior to Excolo, he worked at EY Korea and EY Norway, specializing in global companies.

El Lee is an expert in Government Relations, External Relations, Private and Public Partnerships, and Resource Mobilization. Her professional experience spans the globe: she has lived and worked in the United States, France, Italy, Korea, and Norway. She currently serves as Chief Operating Officer at Excolo, working on international development cooperation projects focused on global health. Previously she worked as East Asia Representative at International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) and External Relations Coordinator at the International Vaccine Institute.

Anthony Flynn has a distinguished background with more than 30 years of resource development experience. Much of Flynn’s development experience has been in global health. Currently he serves as Senior Advisor and Resource Development Strategist at Excolo. Previously he served as Director of Development at icddr,b (formerly, the International Centre for Diarrhoeal Disease Research, Bangladesh) and UCLA Fielding School of Public Health. He also served as Deputy Director General at the International Vaccine Institute, Head of Development at the International AIDs Society, and Development Manager at the International AIDs Vaccine Initiative. 

Prof. Byung Wook Eun is a physician at Eulji University Hospital. He is a medical doctor and professor in Korea (with Educational Commission for Foreign Medical Graduates certificate in 2006) specialized in pediatric infectious diseases with over 70 publications on infectious disease topic. He has held high-level positions in Korean medical professional organizations and has won four professional awards for work in his field.

Prof. Eun received his PhD, Masters, and MD from Seoul National University College of Medicine.

Capucine is a skilled program and partnership manager as well as effective team leader and policy adviser. She has over ten years of experience in Global Health, both in non-profit, academic and government organizations. Currently she serves as Program Manager for the International Coalition to Eliminate HBV (ICE-HBV). She leads the secretariat of the Coalition based at the Doherty Institute for Infection and Immunity in Melbourne, Australia. She also works as Manager of Programs and Partnerships at The Hepatitis Fund. Her work focuses on the design of strategic global health initiatives such as the IAS’ Towards an HIV Cure program, ICE-HBV and EndHep2030.

Dr Ionnis Hodges-Mameltzis is a global health scientist with over 20 years of experience in public health and HIV, viral hepatitis, sexually transmitted infections (STIs), and SARS-CoV-2/COVID-19. He specialised in biomedical HIV prevention with a focus on pre-exposure prophylaxis (PrEP) policy, HIV self-testing (HIVST), and clinical/implementation science for both PrEP and HIVST. He also has experience advising national programs on strategic introduction, scale-up, and access to oral PrEP. Currently, he is focused on COVID-19 global policies for vaccines (mRNA and other platforms), treatment optimisation, contact tracing, and diagnostics (e.g., self-resting with rapid antigen assays).

He received his PhD from the Department of Public Health at the University of Oxford’s St. Peter’s College. He also received his Master’s Degree in Public Health from Yale University and a BA in Biology and Religions & Classics from the University of Rochester.

Dr. Shin Young Park is an instructor in Harvard Medical School and has over 25 years of National Institutes of Health (NIH)- funded research experience at Harvard Medical School and its affiliated hospitals, Boston Children’s Hospital and Beth Israel Deaconess Medical Center. His expertise includes immunology, neurobiology, signal transduction, hematopoietic stem cells, and sickle cell disease. 

He received Bachelor’s and Master’s degrees from Seoul National University, and PhD from the State University of New York at Buffalo (Roswell Park Cancer Institute Division). 

Prof. Sihoon Lee is a Professor of Medicine and Attending Physician at both Gachon University College of Medicine and Gachon University Gil Medical Center, Department of Internal Medicine and Endocrinology. He is a medical doctor and professor specialized in internal medicine and endocrinology with over 70 publications in his field. He has held visiting scientist and professor positions at Harvard Medical School and The University of Tokyo.

Prof. Lee received MD from Yonsei University College of Medicine and his PhD from Yonsei University Graduate School. 

Dr. Tony Michell is an advisor and consultant to government agencies and corporations. He has contributed to studies on employment, regulation, and policy in Korea and other Asian countries for the World Bank and numerous other multilateral agencies. He has assisted various Korean ministries directly, including setting up an overseas aid program in the 1980s that took him on projects to Bangladesh, China, Indonesia, Nepal, Pakistan, and Papua New Guinea.

He has worked in both strategic and hands-on situations with clients from the pharmaceutical industry on government relations, regulatory advice, patient care, and distribution. Clients have include GSK, Roche, Bayer, Zeullig Pharmaceuticals, LG Pharmaceuticals, and Merck. In North Korea he helped establish Pyongsu Pharmaceutical JV and worked with various NGOs and international agencies on infant nutrition, patient care, and use of oriental medicines in the absence of western pharmaceuticals.